Internal Medicine, Rheumatology · Los Angeles, CA
NPI
1144478306
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 Veteran Ave, Rehab Bldg 32-59
Los Angeles, CA, 90024
Phone (310) 825-2448
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,531
74 services
Medicare patients, 2024
13
Average age 65
Drug cost, 2024
$1.3M
2,034 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Karen M Au prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 266 prescriptions and refills. In total Karen M Au wrote 2,034 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 266 | 830 | 106 | $5,421 |
| Prednisone Generic | 220 | 412 | 103 | $2,294 |
| Hydroxychloroquine Sulfate Generic | 216 | 697 | 83 | $6,899 |
| Azathioprine Generic | 189 | 541 | 74 | $7,089 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 163 | 228 | 31 | $208K |
| Leflunomide Generic | 113 | 354 | 52 | $3,804 |
| Sulfasalazine Generic | 107 | 320 | 46 | $7,531 |
| Mycophenolate Mofetil Generic | 68 | 197 | 29 | $14K |
| Xeljanz Tofacitinib Citrate | 57 | 60 | 11 | $157K |
| Allopurinol Generic | 50 | 165 | 23 | $624 |
| Mycophenolic Acid Mycophenolate Sodium | 33 | 104 | 13 | $10K |
| Gabapentin Generic | 30 | 90 | 13 | $769 |
| Meloxicam Generic | 27 | 55 | 15 | $216 |
| Actemra Actpen Tocilizumab | 27 | 27 | Under 11 | $99K |
| Orencia Clickject Abatacept | 25 | 26 | Under 11 | $119K |
Brand drugs: - claims; generic drugs: 1,500 claims; opioid claims: 11.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Karen M Au were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.